nad+ and tirzepatide Tirzepatide: The Metabolism Stack No One's Talking About (But Should Be) Compounded Tirzepatide: Uses, Benefits, and

The Patent Battle That Opened the Door Novo Nordisk filed its semaglutide patent application with Brazil's patent office (INPI) in 2006

Kathy Bates, 77 In October 2024, Oscar-winning actress Kathy Bates opened up about her 100-pound weight loss, clarifying that while Ozempic played a role, it was far from the whole story

Because these compounds target completely different biological systemsone hormonal signaling, one cellular protectionthey do not directly interfere with each other at the receptor or metabolic level

For years, glucagon-like peptide-1 receptor agonists were only available as injectables such as semaglutide and dulaglutide

But one of the biggest indicators is a renewed interest in weight-loss drugs: Both online and in the media, weve seen the rise of Ozempic